Regulatory News:

Under the liquidity contract entered into between VALERIO THERAPEUTICS (Paris:ALVIO) and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30, 2024:

- 392,365 shares - € 144,905.34 - Number of executions on buy side on semester: 108 - Number of executions on sell side on semester: 95 - Traded volume on buy side on semester: 128,013 shares for € 15,133.69 - Traded volume on sell side on semester: 103,822 shares for € 12,955.33

As a reminder:

  • the following resources appeared on the last half year statement on 31 December 2023 on the liquidity account:

- 368,174 shares - € 144,918.05 - Number of executions on buy side on semester: 324 - Number of executions on sell side on semester: 244 - Traded volume on buy side on semester: 304,205 shares for € 69,976.87 - Traded volume on sell side on semester: 223,191 shares for € 56,117.81

  • the following resources appeared on the liquidity account when the activity started:

- 87,612 shares - € 196,423.24

The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22, 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.

Public limited company with a capital of € 21,610,998.20 Registered office: 49 boulevard du Général Martial Valin - 75015 Paris 410 910 095 R.C.S. on the Paris Trade and Companies Register

Valerio Therapeutics Investor Relations investors@valeriotx.com tel : +33 (0) 1 70 38 33 99

Valerio Therapeutics (EU:ALVIO)
過去 株価チャート
から 7 2024 まで 8 2024 Valerio Therapeuticsのチャートをもっと見るにはこちらをクリック
Valerio Therapeutics (EU:ALVIO)
過去 株価チャート
から 8 2023 まで 8 2024 Valerio Therapeuticsのチャートをもっと見るにはこちらをクリック